Tyrer, 1989 - Google Patents
Risks of dependence on benzodiazepine drugs: the importance of patient selectionTyrer, 1989
View PDF- Document ID
- 15163588551466867288
- Author
- Tyrer P
- Publication year
- Publication venue
- BMJ: British Medical Journal
External Links
Snippet
There is considerable concern, sometimes amounting to alarm, in many parts of the world about the risks of dependence on benzodiazepine drugs. Although in some ways this is understandable as benzodiazepines were for many years the most commonly prescribed …
- 239000003814 drug 0 title abstract description 22
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tyrer | Risks of dependence on benzodiazepine drugs: the importance of patient selection | |
| KR20220008824A (en) | How to treat anxiety disorders, headache disorders and eating disorders with psilocybin | |
| US20050118286A1 (en) | Compositions and methods for treatment of nervous system disorders | |
| Ashton | Risks of dependence on benzodiazepine drugs: a major problem of long term treatment | |
| Hardasmalani et al. | Levalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children | |
| Al-Imam | Could Hallucinogens Induce Permanent Pupillary Changes in (Ab) users? A Case Report from New Zealand | |
| Bala et al. | Comparative evaluation of pregabalin and clonidine as preemptive analgesics for the attenuation of postoperative pain following thoracolumbar spine surgery | |
| Cooper et al. | Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers | |
| Hall | Stereotactic neurosurgical treatment of addiction: minimizing the chances of another'great and desperate cure' | |
| Evren et al. | Update on methamphetamine: an old problem that we have recently encountered | |
| Haque | Anxiety disorders: recent global approach to neuro-pathogenesis, drug treatment, cognitive behavioral therapy, and their implications | |
| EP2163244A1 (en) | Agent, pharmaceutical composition, and method for treating the ethyl alcohol and/or narcotic dependence | |
| CN102123703A (en) | 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus | |
| Bahramsari et al. | Comparing the premedication effects of dexmedetomidine, remifentanil and labetalol before electroconvulsive therapy on haemodynamic responses and seizure duration in psychotic patients: A double-blinded clinical trial | |
| MacLean et al. | Hallucinogens and club drugs | |
| Daripa et al. | A rare case of domperidone-induced acute dystonia in a young adult due to consumption of combination drug (proton pump inhibitors with domperidone) and its possible pathomechanism | |
| Shaw | 8 Alcohol and the nervous system | |
| Werry | Anxiolytics in MRDD | |
| JP4422342B2 (en) | Use of cholinergic central nervous system effectors in the treatment of delirium | |
| Mousa et al. | A comparison between the effect of Oral Melatonin and Hydroxyzine for preventing preoperative Anxiety in Pediatric Patients undergoing Adenotonsillectomy: A randomized, double-blinded controlled study | |
| MacLeod et al. | The Psychiatry of Palliative Medicine: The Doctor's Companion to the Classics, v. 2 | |
| Walsh | Anti-anxiety medications: A review for social workers | |
| Singh¹ et al. | “Prospect & Management for Delirium tremens”–A Review | |
| Ozcan et al. | Does a BIS-guided maintenance of anesthetic depth prevent implicit memory? | |
| Cottraux | Combining psychological and pharmacological treatment for specific phobias |